Consider Subcutaneous Insulin to Manage DKA

You’ll hear renewed debate about the optimal insulin regimen for treating diabetic ketoacidosis (DKA) in adults.

A recent retrospective study suggests that subcutaneous insulin, instead of IV, reduces ICU admissions...with no difference in hypoglycemia.

This adds to other limited data suggesting subcutaneous insulin is safe and effective for mild to moderate DKA.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote